UPDATE: Eli Lilly Creates Venture Fund to Invest in Biotechnology Startups | GenomeWeb

NEW YORK, Sept. 20 – Eli Lilly has formed a new $75 million venture capital fund, Lilly BioVentures, that will invest in early-stage biotechnology companies, Lilly said Thursday.  

The venture capital group will make initial investments of up to $5 million in companies developing new biotechnology or biopharmaceutical technologies, and companies developing new or improved platforms for drug discovery, Lilly said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.